PATIENT INFORMATION LEAFLET
Adventan 1mg/g topical emulsion
Methylprednisolone aceponate
Read this leaflet carefully before you start using this medicine because it contains important information for you. -Keep this leaflet, as you may need to read it again. -If you have any questions, ask your doctor or pharmacist. -This medicine has been prescribed for you only. Do not give it to others, even if they have the same symptoms, as it may harm them. -If you experience any side effects, consult your doctor or pharmacist even if they are not listed in this leaflet. See section 4. |
1.What is Adventan emulsion and what it is used for
2.What you need to know before using Adventan emulsion
3.How to use Adventan emulsion
4.Possible side effects
5.Storage of Adventan emulsion
6.Contents of the pack and additional information
Adventan emulsion contains the active substance, methylprednisolone aceponate.
Adventan emulsion is an anti-inflammatory medication (a corticosteroid) for use on the skin.
Adventan emulsion reduces inflammation and allergic reactions in the skin, and reactions associated with excessive multiplication of skin cells (hyperproliferation). Therefore, it reduces redness (erythema), fluid accumulation (edema), and exudate in inflamed skin. It also relieves itching, burning, or pain.
Adventan emulsion is used in the treatment of acute forms of:
Do not use Adventan emulsion:
Warnings and precautions
Consult your doctor or pharmacist before starting to use Adventan emulsion.
Be especially careful if your doctor diagnoses, in addition, a bacterial or fungal skin infection; then, you must also use the additional treatment prescribed for the infection, because if not, the infection may worsen.
Corticosteroids, like the active ingredient MPA of Adventan emulsion, have significant effects on the body. It is not recommended to use Adventan emulsion in extensive areas of the skin or for prolonged periods, because this significantly increases the risk of adverse effects.
To reduce the risk of adverse effects::
If you use Adventan emulsion for conditions other than those for which it has been prescribed, it may mask symptoms and make it difficult to diagnose and treat correctly.
Contact your doctor if you experience blurred vision or other visual disturbances.
If Adventan emulsion is applied to the anal or genital area, some of its ingredients may damage latex products such as condoms or diaphragms. Therefore, they may no longer be effective as contraceptives or as protection against sexually transmitted diseases, such as HIV. Consult your doctor or pharmacist if you need more information.
Children
Use Adventan emulsion as little as possible to reduce the risk of adverse effects.
Do not use Adventan emulsion under impermeable materials to air and water, for example, diapers, unless your doctor has prescribed it.
Adventan emulsion may be used in children between 4 months and 3 years if your doctor has prescribed it. It is not recommended for use in children under 4 months of age.
Use of Adventan emulsion with other medications
No interactions of Adventan emulsion with other medications are known at this time.
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication, including those purchased without a prescription.
Pregnancy and breastfeeding
To avoid any risk to the baby, do not use Adventan emulsion if you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, unless your doctor advises you to.
If your doctor recommends using Adventan emulsion during breastfeeding, do not apply the medication to the breasts; do not put the baby in contact with treated areas.
If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
Adventan emulsion does not affect your ability to drive or operate machinery.
Adventan emulsion contains benzyl alcohol
This medication contains 1.25 g of benzyl alcohol in each 100 g. Benzyl alcohol may cause allergic reactions and/or moderate local irritation.
Follow exactly the administration instructions for this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Unless your doctor tells you otherwise, the dosage is generally as follows:
Use in children
Adventan emulsion can be used in children between 4 months and 3 years if your doctor has prescribed it. No dosage adjustments are required.
Adventan emulsion is not recommended for use in children under four months of age due to a lack of safety data.
If you use more Adventan emulsion than you should
No adverse effects are expected after a single overdose of Adventan emulsion (too large a quantity, too large an area of skin, or too frequent use). Repeated overdoses may cause side effects (see section 4. Possible side effects).
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, or go to a medical center, or call the Toxicology Information Service, phone (91) 562 04 20 (indicating the medication and the amount ingested).
If you forgot to use Adventan emulsion
Do not use a double dose to make up for the missed dose; if you have forgotten a dose, continue with your regular schedule as instructed by your doctor or as described in the leaflet.
If you interrupt treatment with Adventan emulsion
If you interrupt treatment with Adventan emulsion prematurely, the original symptoms of your skin problem may reappear. Please contact your doctor or pharmacist before interrupting treatment with Adventan emulsion.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Adventan emulsion may cause side effects, although not everyone will experience them.
The assessment of side effects is based on the following frequencies:
Very common:may affect more than 1 in 10 patients
Common:may affect up to 1 in 10 patients
Uncommon:may affect up to 1 in 100 patients
Rare:may affect up to 1 in 1,000 patients
Very rare:may affect up to 1 in 10,000 patients
Frequency not known:cannot be estimated from available data
The use of anti-inflammatory medications, called corticosteroids (such as the active ingredient in Adventan emulsion) on the skin may lead to the following side effects (frequency not known):
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: http://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine
Keep this medication out of the sight and reach of children.
Do not store at a temperature above30°C.
Do not use this medication after the expiration date that appears on the packaging, after CAD. The expiration date is the last day of the month indicated.
Shelf life after first opening: 3 months
Medications should not be disposed of through drains or in the trash.Deposit containers and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and medications you no longer need. By doing so, you will help protect the environment.
Composition of Adventan emulsion
Appearance of the product and contents of the packaging
Adventan emulsion is a white skin emulsion (similar to an opaque milk cream) and is presented in tubes of:
The tube is provided with an extractable seal.
Not all packaging sizes may be marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
LEO Pharma A/S
Industriparken 55
DK-2750 Ballerup
Denmark
Responsible for manufacturing:
LEO Pharma Manufacturing Italy S.r.l.
Via E. Schering, 21
20054 Segrate (Milan) - Italy
This medicine is authorized in the member states of the European Economic Area with the following names:
Austria, Finland, Germany, Italy, Portugal: Advantan
Spain: Adventan
Last review date of this leaflet: July 2019
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.